Aptus Pharma to raise Rs 44 cr for funding strategic growth and business expansion

Aptus Pharma has outlined its next phase of growth focused on developing its own manufacturing capabilities, strengthening its Pan-India presence and exploring opportunities in international markets.

The Board of Directors has approved a proposal to raise Rs 44.88 crore through a preferential issue of equity shares to identified investors.